Intimation for Earnings Call - Q2 FY27

Emcure Ref: EPL/CS/SE/0091/2026 Date: October 14, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Intimation for Earnings Call – Q2 FY27 Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform that the Earnings Call for Investors / Analysts will be held on Tuesday, November 03, 2026, at 4.00 p.m. (IST) to discuss the Company’s Unaudited Financial Results (Standalone and Consolidated) and performance for the quarter and half-year ended September 30, 2026. The details of the aforesaid earnings call for Investors/Analysts is enclosed. The transcript and the audio recording of the Earnings Call will be made available on the Company’s website i.e. www.emcure.com and will be intimated accordingly. You are requested to take the above information on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary & Compliance Officer ICSI Membership No.: A25687 Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251